Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Autor: Villoslada P; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain. pvilloslada@clinic.ub.es., Vila G; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Colafrancesco V; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Moreno B; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Fernandez-Diez B; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Vazquez R; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Pertsovskaya I; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Zubizarreta I; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Pulido-Valdeolivas I; Center for Neuroimmunology, Institut d'Investigacions Biomediques August Pi Sunyer, Casanova 145, Centre Cellex 3A, 08036, Barcelona, Spain., Messeguer J; Institute for Advanced Chemistry of Catalonia, Consejo Superior de Investigaciones Cientificas, Barcelona, 08034, Spain., Vendrell-Navarro G; Institute for Advanced Chemistry of Catalonia, Consejo Superior de Investigaciones Cientificas, Barcelona, 08034, Spain., Frade JM; Instituto Cajal, Consejo Superior de Investigaciones Cientificas, Madrid, 28002, Spain., López-Sánchez N; Instituto Cajal, Consejo Superior de Investigaciones Cientificas, Madrid, 28002, Spain., Teixido M; Institute for Research in Biomedicine, Barcelona, 08028, Spain., Giralt E; Institute for Research in Biomedicine, Barcelona, 08028, Spain., Masso M; Bionure Farma SL, Barcelona, 94025, Spain., Dugas JC; Myelin Repair Foundation, Saratoga, NY, 94085, USA., Leonoudakis D; Myelin Repair Foundation, Saratoga, NY, 94085, USA., Lariosa-Willingham KD; Myelin Repair Foundation, Saratoga, NY, 94085, USA., Steinman L; Stanford University, Palo Alto, CA, 94305, USA., Messeguer A; Institute for Advanced Chemistry of Catalonia, Consejo Superior de Investigaciones Cientificas, Barcelona, 08034, Spain.

Publikováno v: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2019 Jul; Vol. 16 (3), pp. 808-827.

Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions.

Autor: Lariosa-Willingham KD; Translational Medicine Center, Myelin Repair Foundation, Sunnyvale, CA, 94085, USA.; Teva Pharmaceuticals, Biologics and CNS Discovery, Redwood City, CA, 94063, USA., Rosler ES; Translational Medicine Center, Myelin Repair Foundation, Sunnyvale, CA, 94085, USA.; Alios BioPharma, South San Francisco, CA, 94080, USA., Tung JS; Translational Medicine Center, Myelin Repair Foundation, Sunnyvale, CA, 94085, USA., Dugas JC; Translational Medicine Center, Myelin Repair Foundation, Sunnyvale, CA, 94085, USA.; Rigel Pharmaceuticals, South San Francisco, CA, 94080, USA., Collins TL; Translational Medicine Center, Myelin Repair Foundation, Sunnyvale, CA, 94085, USA.; NGM Biopharmaceuticals, Inc., South San Francisco, CA, 94080, USA., Leonoudakis D; Translational Medicine Center, Myelin Repair Foundation, Sunnyvale, CA, 94085, USA. dmitri.leonoudakis@tevapharm.com.; Teva Pharmaceuticals, Biologics and CNS Discovery, Redwood City, CA, 94063, USA. dmitri.leonoudakis@tevapharm.com.

Publikováno v: BMC research notes [BMC Res Notes] 2016 Sep 05; Vol. 9 (1), pp. 444. Date of Electronic Publication: 2016 Sep 05.